Helus Pharma Appoints Jill Conwell as Chief People Officer With 20+ Years Pharma Expertise
Helus Pharma named Jill Conwell Chief People Officer, effective immediately, to strengthen its human resources leadership. Conwell brings over two decades of organizational strategy and talent development expertise across the pharmaceutical industry to support the maturation of Helus’s clinical pipeline.
1. Appointment Overview
Helus Pharma has appointed Jill Conwell as Chief People Officer, effective immediately, as part of its effort to enhance human resources functions and organizational strategy. This move aims to bolster the company’s infrastructure ahead of key clinical milestones and potential commercialization phases.
2. Conwell’s Background
Conwell brings more than 20 years of leadership experience from roles at Aclaris Therapeutics, Idera Pharmaceuticals and Shire Pharmaceuticals, where she led talent development, corporate communications and investor relations. Her track record includes scaling organizations to support rapid pipeline advancement and corporate transformation.
3. Strategic Impact
With proprietary NSAs in Phase 3 for major depressive disorder and Phase 2 for generalized anxiety disorder, Helus Pharma requires robust talent acquisition and culture-building to advance its novel serotonergic agonists. Conwell’s expertise in aligning teams and processes is expected to drive recruitment, retention and organizational maturity as the company moves toward late-stage development and commercialization.